Medtech’s Leading Revenue Earners In 2023: Johnson & Johnson Tops $30bn

Pandemic’s Endemic State In 2023 Puts Correction On Testing Revenues

Abbott’s weaker rapid diagnostic sales see the erstwhile industry leader slip down the global 2023 medtech rankings, while Johnson & Johnson passes it on the way up on the back of strong external and internal growth.

Shutterstock

While leading medical device companies, notably Johnson & Johnson, scored revenue gains in 2023, for in vitro diagnostics manufacturers it was largely a different story.

The COVID-19 bubble for medtech businesses has been deflating for some time, most visibly in terms of rapid diagnostic test...

More from Business

More from Medtech Insight

Burden Is Too Heavy For Medtechs To Go It Alone On Complex Medtech AI Projects

 

Medtech companies require expertise to navigate complex AI regulations and integrate AI in medical software while addressing regulatory challenges, claims expert AI consultant with medtech experience.

Ochsner Surgeon In ‘The Big Easy’ Eases Patient’s Pain With Skill And Virtual Reality

 

A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.

Execs On The Move: June 30–July 4, 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.